Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer

IMPORTANCE: Proton pump inhibitors (PPIs) are commonly used drugs to relieve gastrointestinal tract symptoms, but their acid-inhibitory action negatively affects the bioavailability and clinical outcomes of orally administered concomitant drugs. OBJECTIVE: To identify the clinical outcomes of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju-Eun, Kwon, Sun-Hong, Kwon, Swan, Jung, Hye-In, Nam, Jin Hyun, Lee, Eui-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362477/
https://www.ncbi.nlm.nih.gov/pubmed/37477917
http://dx.doi.org/10.1001/jamanetworkopen.2023.24852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362477/
https://www.ncbi.nlm.nih.gov/pubmed/37477917
http://dx.doi.org/10.1001/jamanetworkopen.2023.24852

Ejemplares similares